drugset / Trial / NCT02858973
A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This is randomized, double-blind, placebo-controlled, multiple ascending dose study of Q203 in healthy volunteers conducted at one study center in the United States
Timeline
- Start
- 2016-08
- Primary completion
- 2018-05
- Completion
- 2018-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telacebec | Small molecule | — | Oral |
Indications
No indication recorded.